was determined in mutants expressing a truncated form of DFz2 lacking the Cterminal portion of the receptor (dfz2 C1 ). The nuclear staining pattern was eliminated in homozygous dfz2 C1 (S2) and in dfz2 C1 over a deficiency of the dfz2 chromosomal region (dfz2 C1 /Dfdfz2) (Fig. S1 , B and C). Propidium iodide (PI) was used to stain chromatin, with samples being additionally treated with RNAse A (5 µg/µl) for 1 hour prior to PI staining. For immunocytochemistry, Drosophila third instar larvae were dissected and treated as described previously (S9) , and muscles 6 and 7 from abdominal segments 3 and 4 were analyzed. Comparisons between genotypes were performed in samples processed simultaneously and by using the same confocal acquisition parameters using a Zeiss laser scanning confocal microscope.
Statistical methods
Differences between genotypes were evaluated by analysis of variance (ANOVA) for a mixed model by restricted maximum likelihood (REML) and using an unstructured covariance structure. In the presence of a significant effect of genotype, pairwise comparisons were performed using the Tukey HSD procedure. The distributional characteristics of bouton measurements were evaluated by visual inspection of histograms of residuals from the fitted ANOVA model and by application of the Kolmogorov-Smirnov goodness of fit test for normality.
Internalization assay
The internalization assay was performed and quantified as described before (S14). Briefly, samples were dissected in a 0.1 mM Ca +2 Drosophila saline, and antibodies to DFz2-N added prior to incubation for 2 hours at 4°C. Samples were then shifted to room temperature for defined periods of time, fixed, and labeled with Alexa 647-conjugated secondary antibody under nonpermeabilization conditions to label external DFz2. Samples were then permeabilized and labeled with an FITC-conjugated secondary antibody.
Quantifications of images
Nuclear DFz2 immunoreactivity was quantified by counting the average number of distinct DFz2-C immunoreactive spots per nucleus at muscles 6 and 7
(segments A3 and 4), in preparations double stained with antibodies to tubulin and DFz2-C. The boundaries of muscle nuclei were distinguished with antibodies to tubulin (e.g., Fig. 1F ) or lamin-C (Fig. S1 ). Number of samples for each genotype were N = 20 for wild type, 12 for Shi-DN, 12 for Glued-DN, 15 for Wg presynaptic overexpression, 10 for wg ts pulsed to restrictive temperature for 12 hours before the wandering stage, 12 for DFz2 postsynaptic overexpression, and 9 for DFz2-DN.
To measure the differential distribution of nuclear DFz2-C spots in nuclei proximal and distal to NMJs, DFz2-C immunoreactive spots at muscle 6 (segments A3 and A4) were counted. Muscle 6 contains two longitudinal rows of nuclei localized in a stereotypical manner, a row close to muscle 13 (top nuclear row), and a row close to muscle 7 where the NMJ is located (bottom nuclear row). The number of DFz2-C spots in proximal nuclei was determined by averaging the number of spots in the 3 nuclei closest to the NMJ at the bottom nuclear row. The number of spots in distal nuclei was determined by averaging the number of spots in nuclei of the top nuclear row that abutted the segmental boundary. Quantification of the number of DFz2-C-positive spots in each nucleus demonstrated that spots were more numerous in nuclei close to the NMJ compared with those distal, and that this was enhanced by expressing Wg presynaptically (Fig. S1D ).
To quantify the accumulation of DFz2 outside the nuclear boundary, the total number of spots juxtaposed to the boundary of every nucleus of muscle 6 (A3, A4) determined by the staining with antibodies to tubulin, was counted in samples double stained with antibodies to tubulin and DFz2-C.
For quantification of signal intensity in the internalization assay we used the Zeiss LSM5 PASCAL (version 3.2) image analysis software. Briefly, the immunolabeled region surrounding individual boutons (at muscles 6 and 7, abdominal segment 3) was manually traced in a single, medial confocal slice, and the mean relative intensities (on a scale of 0 to 255) of staining in the green channel (internalized DFz2) and the blue channel (external DFz2) across the selected area were measured. For measurements of perinuclear DFz2-N immunoreactivity, the mean intensity of staining in the green channel, in an area between the muscle nucleus and a concentric circle of a radius of 5 µm larger than the nuclear radius, was measured at a nuclear midline confocal slice. A mean intensity value of a similar area away from the nucleus was measured and subtracted from the previous value to normalize background levels in the various samples. Values were normalized by dividing the signal intensities by area of the section and were then plotted.
To determine the number of synaptic boutons in various genotypes, third instar body wall muscles were dissected and stained with antibodies to HRP to visualize NMJs, and boutons were counted under a fluorescence microscope at muscles 6 and 7 (segments A3 and A4 medium containing 10%FBS, penicillin (100 U/µl) and streptomycin (100 µg/µl).
3x2ml-wells/sample of 60-80% confluent S2 cells were transfected with 1.5 µg DNA using Cellfectin and Serum Free Medium (Invitrogen). Thirty-six hours after transfection, cells were harvested, resuspended in homogenization buffer and protein dye. Samples were loaded onto 6% or 15% acrylamide gel for subsequent Western blot procedures. DFz2 mutations were generated using the PCR-based QuikChange site-directed mutagenesis kit (Stratagene). Full length To provide a source of Wg for DFz2-transfected S2 cells we added Wgconditioned medium as follows. S2HSWG (+) cells were heat shocked to produce WG. GAGs (10 µg/ml heparin and 10 µg/ml chondroitin sulfate) were then added to release WG from the cell surface as described (S13). Next, the conditioned medium was added to transfected S2 cells (Fig. S4F) . After 48-60 hours' incubation, immunocytochemistry was performed as described before (S15).
When S2 cells are transfected with DFz2 in the absence of Wg, immunoreactive spots are observed in the cytoplasm, but no signal is observed inside the nucleus. The amount of cleaved DFz2-C (8-kD fragment) was not affected by culturing DFz2-transfected S2 cells in the presence of Wg-conditioned medium.
For overexpression and rescue of dfz2 mutant phenotypes, full-length DFZ2, ∆SGKTLESW, and DFz2-C region were subcloned using Eag1 and XhoI in frame to a 6 Myc tag at the 5' end of NT-pUAST (kind gift from Dr. Marc Freeman). The Dfz2C fragment (aa 617-aa 694) with a Myc tag (MEQKLISEEDLNE) and an NLS tag (PKKKRKV) at its N terminus was cloned into pUAST for germline transformation.
Western blots
Western blots of S2 cells and body wall muscles were performed as previously described (S16). In the Western blots shown in Fig. 2 and Fig. S2 , proteins in the upper and the lower panels were separated in a 6% or a 15% SDS-PAGE gel respectively. We also examined DFz2 in KC167 cells transfected with DFz2. We observed no DFz2 cleavage product in these cells.
To verify the observations of DFz2 cleavage with a marker independent of the DFz2-C antibody, we also generated a DFz2 construct containing 8 Myc tags inserted after the site of cleavage and expressed it in S2 cells for Western analysis. We found that the cleaved fragment could also be detected with antibodies to Myc (Fig. S5) . We also tested if the amount of DFz2 cleaved was dependent on the presence of Wg. For this experiment, DFz2-S2 cells were cultured in the presence and absence of Wg-conditioned medium, and cell extracts analyzed by Western blot. The amount of Dfz2 cleaved in the two situations was measured using a PhosphorImager and expressed as a ratio of full length DFz2. No difference in the amount of DFz2-C was detected in this blot (Fig. S4H) .
We also tested whether another member of the DFz family, DFz1 was cleaved in a manner similar to DFz2, although DFz1 lacks the region identified as part of the cleavage site in DFz2. For these experiments, a DFz1 cDNA containing a V5 tag at its C terminus was transfected into S2 cells, and cell extracts examined by Western blot. We detected no cleavage of DFz1 (data not shown).
Our immunocytochemical observations suggest that DFZ2-C is not detected in epithelial cells and neurons. We also addressed this issue by performing
Western blots of adult heads and imaginal discs overexpressing DFz2. No cleavage product was detected in the blots (data not shown). Fig. S1 . DFz2-C is localized to spots in muscle nuclei, but not in the nuclei of epithelial cells. 
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